Epigenetic information is embedded in covalent modifications of DNA and histones and in the nature of histones within the nucleosome. In most cases, the nucleosome consists of an octamer of four canonical histones synthesized during the S phase of the cell cycle and incorporated into the nucleosome in a replication-dependent manner. In some genomic loci, cell types or developmental stages, histone variants may replace canonical histones. Expression of histone variants is not restricted to the S phase, and they can be assembled into the nucleosome in replication-independent processes, through alternative histone deposition pathways [1][2][3] [4] . Two ubiquitous variants of canonical histones H3.1 in mammals are CENP-A and H3.3. CENP-A is a centromere-specific histone H3 variant assembled onto centromeric chromatin during late M-early G1 phases of the cell cycle 1,5 . Deposition of CENP-A at the centromere requires histone chaperone HJURP 6-8 . H3.3 is synthesized throughout the cell cycle and localized in gene bodies as well as in pericentric and telomeric heterochromatin [1][2][3] [4] . Two principal H3.3 deposition pathways are mediated by histone chaperones death domain-associated protein 6 (DAXX) and HIRA [9] [10] [11] [12] [13] . DAXX cooperates with a SNF2-like chromatin remodeler, ATRX, to direct the deposition of H3.3 onto pericentric and telomeric heterochromatin 12-14 , whereas HIRA mainly targets H3.3 to gene bodies 2-4 . A third chaperone, DEK, has been implicated in the assembly of H3.3 nucleosomes and transcriptional activation of a nuclear receptor 15 . H3.3 is highly enriched during early development and in neuronal cells [1][2][3] [4] . It has important roles in reprogramming the paternal genome in fertilized eggs, and somatic mutations of H3.3 have been implicated in the development of pediatric glioblastomas [16] [17] [18] .
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To understand the assembly of H3.3 nucleosomes, it is necessary to know how H3.3 differentially recognized by its chaperones. DAXX and HIRA share no known sequence homology, and their sequences give no clues as to how they might bind histones, not to mention their precise specificity needed to distinguish the five-amino acid difference between H3.3 and H3.1. Structural studies can provide atomic-resolution details of histone-chaperone interactions, as exemplified by the structures of several H3(variant)-H4 complexes with their respective chaperones [19] [20] [21] [22] [23] . Here we set out to investigate the molecular mechanism of specific recognition of H3.3 by DAXX. We have determined the structure of the histone-binding domain of human DAXX (DAXX HBD) in complex with histones H3.3 and H4 and identified and analyzed the determinants for the binding specificity between H3.3 and DAXX by using a combination of structural, biochemical and cellular co-localization approaches.
RESULTS

Overall structure of DAXX HBD-H3.3-H4
A previous study identified that residues 183-417 of DAXX encompass the domain for binding the H3.3-H4 complex 14 . By systematic deletion of DAXX and co-purification with the full-length H3.3-H4 complex, we have succeeded in crystallizing and solving a 2.8-Å structure of the histone-binding domain of human DAXX (DAXX HBD, residues 184-390) in complex with histones H3.3 and H4 ( Table 1) . The structure shows that DAXX HBD mainly consists of six α-helices, α1-α6, which can be separated into three subdomains on the basis of whether the helices are interacting with each other: subdomain 1 includes α1-α2, subdomain 2 is composed of α3-α5, and subdomain 3 consists of α6 (Fig. 1a) . Subdomain 1 interacts with H3.3 regions spanning αN, α1 and its C-terminal loop and the N-terminal part of α2. Subdomain 2 contacts both H3.3 and H4. Helix α5 packs in an a r t i c l e s antiparallel manner against α2, the central helix of the histone-fold domain of H3.3, whereas the N-terminal end of α4 interacts with the loop connecting α2 and α3 of H3.3. The interaction between subdomain 2 of DAXX HBD and H4 occurs in two regions: (i) the loop connecting α3 and α4 of DAXX HBD, which contacts H4 through its loop between α1 and α2 and the C-terminal end of α1, and (ii) the very C-terminal tail of H4, which is stabilized by interaction with the C-terminal region of α5 of DAXX HBD. Helix α6 of the DAXX HBD packs in an antiparallel manner against α2 in histone H4 and also interacts with H3.3 through its C-terminal helix, α3 (Fig. 1a) . The binding between DAXX HBD and H3.3-H4 involves a mixture of hydrophobic and polar interactions (Fig. 1b) . The interaction between DAXX HBD and the H3.3-H4 heterodimer buries a total surface area of 6,544 Å 2 , consistent with a stable heterotrimeric complex that can withstand purification steps at a 1 M salt concentration.
Comparison of nucleosomal and DAXX-bound H3.3-H4
Comparison of the structures of the DAXX HBD-bound H3.3-H4 heterodimer and the H3.3-H4 half tetramer in the H3.3-containing nucleosome core particle (NCP) 24 reveals major conformational differences of H3.3 (Fig. 2a,b) . Most notably, the αN of H3.3, which interacts with helices α1 and α2 of DAXX HBD, is oriented in an opposite direction with respect to the corresponding helix in the nucleosomal complex (Fig. 2a) . The αN of H3.3 is normally involved in interacting with DNA near the entry-exit point in the NCP, and the observed orientation in the present structure indicates a major conformational rearrangement of the helix, deviating from the conformation that favors the wrapping of the DNA in the nucleosomal complex. Also of note, helices α1 and α2 of DAXX HBD would block the wrapping of nucleosomal DNA if the DAXX HBD-bound H3.3-H4 heterodimer were superimposed with one of the nucleosomal H3.3-H4 heterodimers (Fig. 2c) . In addition, the α3 in H3.3 is tilted away from the α2 of histone H4; the last turn of α2 in H3.3 is unwound, and the loop between α2 and α3 in H3.3 is pulled toward the α4 in DAXX HBD (Figs. 2b and 1a) . The conformation of α3 and the C-terminal portion of α2 is critical for the formation of a H3.3-H4 tetramer through H3.3-H3.3 interactions, as observed in the structure of the H3.3-containing NCPs 24 . The present conformation of α2 and α3 prevents the dimerization of H3.3-H4 heterodimers, owing to potential steric clashes. The middle part of the α5 of DAXX HBD also poses a spatial hindrance on the association of another H3.3-H4 heterodimer (Fig. 2c) . It is interesting to note that all structures of histone chaperone-H3(variant)-H4 complexes determined to date npg a r t i c l e s the corresponding H3.1 residues are enclosed in parentheses. Three residues, Ala87 (Ser87), Ile89 (Val89) and Gly90 (Met90), are located on the first turn of the α2 of H3.3 or H3.1 (Fig. 3a) . Previous studies have shown that these three residues are critical for specific functions of H3.3 (ref. 10). In the co-crystal structure, Ser31 is disordered and Ser96 is involved in interactions with H4, which supports the reported observations that they are not determinants of H3.3 specificity in DAXX binding 14 . Indeed, the H3.3 region where Ala87, Ile89 and Gly90 are located interacts with DAXX HBD (Fig. 3a) . Ala87 in H3.3 is situated in a shallow hydrophobic pocket formed by the Cys338 and Leu340 located on the loop connecting α5 and α6 in DAXX HBD (Fig. 3a) . The distance between the Cβ of Ala87 and the nearest atoms of Cys338 and Leu340 is ~4 Å, whereas His339, a polar residue, next to Cys338 and Leu340 is more than 6.5 Å away from Ala87. Ile89 in H3.3 is bound in a hydrophobic pocket formed by Leu210, Leu215 and Tyr222, which are located in α2 and its preceding loop in DAXX HBD (Fig. 3a) . Finally, Gly90 has no side chain, and the closest DAXX residue is Tyr222, whose nearest atom is at a distance of ~3.4 Å (Fig. 3a) . The Cα atom of Gly90 directly faces Glu225 and Lys229 in DAXX, which are ~5.3 Å and ~6.2 Å away, respectively. With this structural knowledge in hand, we set out to assess the importance of each of these three residues in H3.3 (and H3.1) and the contributions of their cognate binding sites in DAXX in the specific recognition of H3.3. A previous study using in vitro glutathione S-transferase (GST) pulldown and co-immunoprecipitation methods showed that mutating each of the H3.3 residues to their H3.1 counterparts did not abrogate DAXX binding 14 . Conversely, changing each of the corresponding amino acids in H3.1 did not show markedly increased binding to DAXX, either 14 . We first tested co-localization of DAXX and H3.3 by using a LacO-LacI targeting system in the A03_1 cell line 25 . In these experiments, plasmids carrying full-length DAXX or its derivative fused with mCherry and LacI, and H3.3, H3.1 or their derivatives fused with ECFP, were cotransfected into A03_1 cells (Fig. 3b) . Consistent with the reported results 14 , we observed co-localization of A87S, I89V and G90M mutants of H3.3 with DAXX (Fig. 3c ). An A87S G90M double mutant of H3.3 showed reduced co-localization with DAXX, whereas virtually no co-localization of an A87S I89V G90M triple mutant was detected ( Fig. 3c and  Supplementary Fig. 1a) . In contrast, mutants with single-amino acid substitutions in H3.1, S87A and M90G gained the ability to co-localize with DAXX. To assess whether co-localization of the H3.1 mutants with DAXX implies a physical interaction, a hemagglutinin (HA)-tagged S87A mutant of H3.1 (H3.1 S87A) and a Flag-tagged DAXX were co-transfected in HEK293T cells, and their association was analyzed by co-immunoprecipitation. Also, a GST pulldown experiment was performed using bacterially expressed GST-DAXX HBD and the H3.1 S87A-H4 mutant complex. Both the co-immunoprecipitation and GST pulldown results support a direct interaction between H3.1 S87A and DAXX (Fig. 3d and Supplementary Fig. 2a) . The above a r t i c l e s data suggest that the presence of either an alanine at residue 87 or a glycine at residue 90 is sufficient for DAXX binding.
H3.3-specific binding sites in DAXX HBD
To probe the nature of the binding sites and assess their binding preferences for the three H3.3-specific residues, we mutated DAXX and tested the binding of these mutants to H3.3 and H3.1. We first examined the H3.3 Ala87 binding site in DAXX, which consists of hydrophobic residues Cys338 and Leu340 (Fig. 3a) . Because of the hydrophobic nature of Ala87, we reasoned that changing Cys338 and Leu340 to polar residues would reduce the binding of H3.3 and H3.1 S87A. As expected, GST pulldown using the DAXX C338S L340N mutant showed detectable but subtle reduction of H3.1 S87A and H3.3 binding (Fig. 3d) . Co-localization of H3.1 S87A with DAXX was affected to a greater extent than that of H3.3 by the C338S L340N mutation ( Fig. 4a and Supplementary Fig. 1b) . For comparison, the G90M mutant of H3.3, which differs from H3.1 S87A at the Ile89 (Val89) site, displayed a markedly reduced but still detectable co-localization with the C338S L340N mutant of DAXX (Fig. 4a) .
When the Ser87 of H3.1 is substituted with a similarly sized but hydrophobic cysteine, the H3.1 S87C mutant co-localized with the wild-type DAXX but not the C338S L340N mutant, much like the H3.1 S87A mutant (Fig. 4a) . Altogether, the above data indicate that the hydrophobic nature of Ala87 and a hydrophobic binding environment in DAXX are important for the preferential binding of H3.3 at this site. Next, we examined H3.3's Gly90 binding site in DAXX, which contains a pair of charged residues, Glu225 and Lys229 (Fig. 3a) . We first changed them to a pair of hydrophobic residues, two methionines. Coimmunoprecipitation and GST pulldown analyses showed that H3.3 interacted well with the E225M K229M mutant of DAXX ( Fig. 4b  and Supplementary Fig. 2b) . Notably, the DAXX mutant also gained the ability to interact with H3.1 (Fig. 4b) . Co-localization experiments corroborated the co-immunoprecipitation and GST pulldown results and showed that a polar but neutral E225Q K229Q mutant of DAXX co-localized with H3.1 (Fig. 4c and Supplementary Fig. 1c) . A reasonable explanation of the above results is that Gly90 of H3.3 is not specifically recognized by DAXX, but rather a methionine at this position in H3.1 is incompatible with the binding site in DAXX. The inability of a methionine to bind the Glu225-Lys229 site in DAXX is not due to its size, as superposition of α2 in H3 with that in H3.3 shows that Glu225 and Lys229 allow ample space for a methionine (Fig. 3a) . Hence, we conclude that DAXX has a preference against a hydrophobic residue at this position of histone H3.3 (or H3.1). Lastly, Tyr222 bisects the Gly90 and Ile89 histone-binding sites in DAXX. The latter is hydrophobic; changing Tyr222 to a charged residue, glutamate, disrupted DAXX's ability to bind H3.3 in a GST pulldown assay (Fig. 4b) . Co-localization analyses are consistent with the notion that the H3.3 Ile89 binding site on DAXX needs to be hydrophobic (Supplementary Fig. 3 ).
DISCUSSION
Here we have focused our study to understand the molecular mechanism by which the specificity for H3.3 is achieved by DAXX. It is remarkable that DAXX can precisely distinguish H3.3 and H3.1 with only three amino acid differences in the histone-fold domain. Our analyses here revealed that two H3.3 residues, Ala87 and Gly90, are principal determinants for specific recognition by DAXX HBD. Mutational studies indicated that any one of the two H3.3 residues could direct the recognition by DAXX. The data presented here suggest a chiefly two-site recognition mechanism: Ala87 of H3.3 is a small hydrophobic residue preferred by the shallow hydrophobic pocket formed by Cys338 and Leu340 in DAXX, and DAXX preferentially selects the Gly90 of H3.3 over the hydrophobic residue Met90 of H3.1. Clearly, Ile89 in H3.3 also has an effect on DAXX binding, but most likely through a less specific but stronger hydrophobic interaction between H3.3 and DAXX due to its bulkier side chain, compared to that of Val89 in H3.1. It is interesting that an alanine at residue 87 or a glycine at residue 90 can independently direct the recognition by DAXX. This observation suggests that optimal binding at either of these two sites can overcome the presence of a nonoptimal amino acid at the other site.
One puzzle from the structural results is that DAXX HBD binds a large surface area, most of which has the same amino acid composition in H3.3-H4 and H3.1-H4 complexes: how would the difference of a small number of amino acids in H3.3 and H3.1 result in drastically different DAXX binding properties? In fact, similar observations have been made with other chaperone-histone complexes [19] [20] [21] [22] [23] . A plausible explanation is that DAXX and other histone chaperones may first survey the specific residues in their cognate histones before fully engaging in chaperone-histone interactions. Obviously, additional or alternative possibilities, such as post-translational modifications and participation of other proteins or nucleic acids in an in vivo environment, may contribute to the recognition and regulation of chaperone-histone interactions.
In conclusion, the structural basis of specific interactions between H3.3 and DAXX learned here should be useful for delineating the various pathways of H3.3 deposition and facilitate our understanding of the molecular mechanisms of the biological and pathological functions of H3.3.
METHODS
Methods and any associated references are available in the online version of the paper. 
